Enanta Pharmaceuticals (ENTA) Cash from Financing Activities (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Cash from Financing Activities of -$7.3 million for Q1 2026, down 5.92% year-on-year from -$7.8 million in Q1 2025, and down 111.37% on a QoQ basis from $64.1 million in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Cash from Financing Activities data on file, last reported at -$7.3 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 5.92% year-over-year to -$7.3 million; the trailing twelve-month figure through Mar 2026 stood at $42.1 million (up 263.57% YoY), and the FY2025 full-year result was -$26.6 million, up 3.65% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$7.3 million, down from $64.1 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $199.9 million in Q2 2023 and bottomed at -$8.3 million in Q3 2025.
- The 5-year median for Cash from Financing Activities is -$5.0 million (2024), against an average of $12.4 million.
- The widest annual swing landed in 2023, when Cash from Financing Activities surged 4751.33%; it then sank 31269.57% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $301000.0 in 2022, then slumped by 2541.86% to -$7.4 million in 2023, then surged by 32.16% to -$5.0 million in 2024, then jumped by 1386.32% to $64.1 million in 2025, then slumped by 111.37% to -$7.3 million in 2026.
- The last three Cash from Financing Activities figures came in at -$7.3 million (Q1 2026), $64.1 million (Q4 2025), and -$8.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -7.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.30 Mn |
| Mar 31, 2026 | -7.30 Mn |
| Dec 31, 2025 | 64.14 Mn |
| Dec 31, 2025 | 64.14 Mn |
| Sep 30, 2025 | -8.32 Mn |
| Sep 30, 2025 | -8.32 Mn |
| Jun 30, 2025 | -6.42 Mn |
| Jun 30, 2025 | -6.42 Mn |
| Mar 31, 2025 | -6.89 Mn |
| Mar 31, 2025 | -6.89 Mn |
| Dec 31, 2024 | -4.99 Mn |
| Dec 31, 2024 | -4.99 Mn |
| Sep 30, 2024 | -7.22 Mn |
| Sep 30, 2024 | -7.22 Mn |
| Jun 30, 2024 | -6.65 Mn |
| Jun 30, 2024 | -6.65 Mn |
| Mar 31, 2024 | -6.41 Mn |
| Mar 31, 2024 | -6.41 Mn |
| Dec 31, 2023 | -7.35 Mn |
| Dec 31, 2023 | -7.35 Mn |
| Sep 30, 2023 | -23,000.00 |
| Sep 30, 2023 | -23,000.00 |
| Jun 30, 2023 | 199.88 Mn |
| Jun 30, 2023 | 199.88 Mn |
| Mar 31, 2023 | -2.03 Mn |
| Mar 31, 2023 | -2.03 Mn |
| Dec 31, 2022 | 301,000.00 |
| Dec 31, 2022 | 301,000.00 |
| Sep 30, 2022 | 2.93 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 4.12 Mn |
| Jun 30, 2022 | 4.12 Mn |
| Mar 31, 2022 | 3.35 Mn |
| Mar 31, 2022 | 3.35 Mn |
| Dec 31, 2021 | 9.63 Mn |
| Dec 31, 2021 | 9.63 Mn |
| Sep 30, 2021 | 943,000.00 |
| Sep 30, 2021 | 943,000.00 |
| Jun 30, 2021 | 686,000.00 |
| Jun 30, 2021 | 686,000.00 |
| Mar 31, 2021 | 1.15 Mn |
| Mar 31, 2021 | 1.15 Mn |
| Dec 31, 2020 | 299,000.00 |
| Dec 31, 2020 | 299,000.00 |
| Sep 30, 2020 | 233,000.00 |
| Sep 30, 2020 | 233,000.00 |
| Jun 30, 2020 | 3.23 Mn |
| Jun 30, 2020 | 3.23 Mn |
| Mar 31, 2020 | 4.36 Mn |
| Mar 31, 2020 | 4.36 Mn |
| Dec 31, 2019 | 1.17 Mn |
| Dec 31, 2019 | 1.17 Mn |
| Sep 30, 2019 | 687,000.00 |
| Sep 30, 2019 | 687,000.00 |
| Jun 30, 2019 | 490,000.00 |
| Jun 30, 2019 | 490,000.00 |
| Mar 31, 2019 | 257,000.00 |
| Mar 31, 2019 | 257,000.00 |
| Dec 31, 2018 | 1.14 Mn |
| Dec 31, 2018 | 1.14 Mn |
| Sep 30, 2018 | 1.03 Mn |
| Sep 30, 2018 | 1.03 Mn |
| Jun 30, 2018 | 2.97 Mn |
| Jun 30, 2018 | 2.97 Mn |
| Mar 31, 2018 | -6,000.00 |
| Mar 31, 2018 | -6,000.00 |
| Dec 31, 2017 | 417,000.00 |
| Dec 31, 2017 | 417,000.00 |
| Sep 30, 2017 | 1.01 Mn |
| Sep 30, 2017 | 1.01 Mn |
| Jun 30, 2017 | 190,000.00 |
| Jun 30, 2017 | 190,000.00 |
| Mar 31, 2017 | -211,000.00 |
| Mar 31, 2017 | -211,000.00 |
| Dec 31, 2016 | 31,000.00 |
| Dec 31, 2016 | 31,000.00 |
| Sep 30, 2016 | 61,000.00 |
| Sep 30, 2016 | 61,000.00 |
| Jun 30, 2016 | 1.97 Mn |
| Jun 30, 2016 | 1.97 Mn |
| Mar 31, 2016 | 530,000.00 |
| Mar 31, 2016 | 530,000.00 |
| Dec 31, 2015 | 146,000.00 |
| Dec 31, 2015 | 146,000.00 |
| Sep 30, 2015 | 159,000.00 |
| Sep 30, 2015 | 159,000.00 |
| Jun 30, 2015 | 122,000.00 |
| Jun 30, 2015 | 122,000.00 |
| Mar 31, 2015 | 245,000.00 |
| Mar 31, 2015 | 245,000.00 |
| Dec 31, 2014 | 2.01 Mn |
| Dec 31, 2014 | 2.01 Mn |
| Sep 30, 2014 | 44,000.00 |
| Sep 30, 2014 | 44,000.00 |
| Jun 30, 2014 | 474,000.00 |
| Jun 30, 2014 | 474,000.00 |
| Mar 31, 2014 | 557,000.00 |
| Mar 31, 2014 | 557,000.00 |
| Dec 31, 2013 | 89,000.00 |
| Dec 31, 2013 | 89,000.00 |
| Sep 30, 2013 | 122,000.00 |
| Sep 30, 2013 | 122,000.00 |
| Jun 30, 2013 | -1.45 Mn |
| Jun 30, 2013 | -1.45 Mn |
| Mar 31, 2013 | 59.55 Mn |
| Mar 31, 2013 | 59.55 Mn |
| Dec 31, 2012 | -1.32 Mn |
| Dec 31, 2012 | -1.32 Mn |
| Sep 30, 2012 | -991,000.00 |
| Sep 30, 2012 | -991,000.00 |
| Jun 30, 2012 | -25,000.00 |
| Jun 30, 2012 | -25,000.00 |